Search Results
-
FILTER BY DATEAll Time
-
-
FILTER BY RELEVANCEMost Relevant
-
-
FILTER BY CONTENT TYPEAll Content Types
-
Facebook Inc. took a momentous action last week. And I don’t mean its announced intention to sell shares for $28 to $35 in an initial public offering later this month.
This event will discuss organ donation.
Why can't our opponents be reasonable? In his new book, “The Righteous Mind: Why Good People Are Divided by Politics and Religion,” social psychologist Jonathan Haidt explores the origins of morality in our rapid and automatic moral intuitions.
In October of 2009, Kumud Majumder, the father of an 11-year-old son with advanced leukemia, joined a lawsuit challenging the federal ban on compensating bone-marrow donors. He wanted to save his son's life. Last week Mr. Majumder and his co-plaintiffs enjoyed a victory. The U.S. Court of Appeals for the Ninth Circuit ruled that the majority of bone-marrow donors may lawfully be compensated.
Roughly 10% of all organ transplants in the world are obtained on the black market. A new investigation by puts a brutal face on that underground world.
Our nation's current organ donation system relies on altruism alone, but a regime of donor compensation would be better.
When Altruism Isn't Enough explores the key ethical, theoretical, and practical concerns of a government-regulated donor compensation program.







